Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001048477-24-000006
Filing Date
2024-02-12
Accepted
2024-02-12 15:04:06
Documents
3
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 wk-form5_1707768227.html 5  
1 FORM 5 wk-form5_1707768227.xml 5 3441
2 EX-24 section16filingspowerofa.htm EX-24 3887
3 section16filingspowerofa001.jpg GRAPHIC 219313
  Complete submission text file 0001048477-24-000006.txt   310903
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Issuer) CIK: 0001048477 (see all company filings)

EIN.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O BIOMARIN PHARMACEUTICAL INC. 105 DIGITAL DRIVE NOVATO CA 94949
Business Address
Mueller Brian (Reporting) CIK: 0001514980 (see all company filings)

Type: 5 | Act: 34 | File No.: 000-26727 | Film No.: 24619365